EUVIMEDEUVIMED entdecken
Crossref

A novel cycloastragenol-encapsulated carboxymethyl chitosan-silk fibroin hydrogel combined with sucralfate alleviates MNNG-induced chronic atrophic gastritis by targeting HIF-1α and VEGF signaling pathways

Jianyu Ren, Qianqian Jiang, Kaiwei Wu

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-12 · 398 (12) · 17303-17323

DOI: 10.1007/s00210-025-04242-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 09.06.2025. Verfasst von Jianyu Ren und 2 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Chinese Medicine Department, Dongying People's Hospital (Dongying Hospital of Shandong Provincial Hospital Group), No. 317, Dongcheng Sou…. Hauptthemen laut MEDLINE: Chitosan, Fibroins, Gastritis, Atrophic, Sucralfate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In order to treat chronic atrophic gastritis (CAG) caused by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), the present study successfully fabricated a carboxymethyl chitosan (CMC)-silk fibroin (SF) hydrogel encapsulating cycloastragenol (Cyl) and sucralfate (SC) (Cyl-SC@SF/CMC). This represents a substantial improvement in drug delivery and therapeutic efficacy. The SEM analysis shows the porosity of fabricated Cyl-SC@SF/CMC revealed a network of pores inside the hydrogel. Thermogravimetric and rheological investigations confirmed that the hydrogel was the structure of SF and CFC forming intermolecular hydrogen bonds. A model was developed to stimulate the impact of MNNG on gastric epithelial cells. Furthermore, cell counting kit-8 (CCK-8) assay was employed to evaluate the viability and proliferation of MNNG induced CAG in GES-1 after exposed to fabricated Cyl-SC@SF/CMC hydrogels. The results displayed that Cyl-SC@SF/CMC is superior than SC@SF/CMC in promoting the growth of GES-1 cells while simultaneously reducing MNNG-triggered damage to GES-1 cells and mitochondrial dysfunction. Moreover, cell migration and invasion analysis revealed that Cyl-SC@SF/CMC significantly enhanced migration and suggesting its role in tissue repair and regeneration. Moreover, in CAG rats, Cyl and SC in the hydrogel exerted therapeutic effects by considerably reducing histological damage in gastric tissues as evidenced by histopathological examinations. Furthermore, the pharmacokinetics analysis showed that Cyl-SC@SF/CMC formulation exhibited a higher area under the curve (AUC0-t) and longer mean residence time (MRT) in both blood and gastric tissues compared to SC@SF/CMC, suggesting enhanced therapeutic efficacy. Due to the importance of tumor-induced angiogenesis in the advancement of inflammation and malignance, this study also examines the levels of mRNA and protein expression of the HIF-1α and VEGF signaling pathways in vivo using Western blot qRT-PCR analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanFibroinsGastritis, AtrophicSucralfateAnimalsHydrogelsRatsHypoxia-Inducible Factor 1, alpha SubunitCell LineMaleSignal TransductionVascular Endothelial Growth Factor ARats, Sprague-DawleyHumansAnti-Ulcer Agents

Stichwörter der Autor:innen

AngiogenesisCycloastragenolGastritisInflammationSilk fibroin

Substanzen

ChitosanHydrogelsFibroinscarboxymethyl-chitosanHypoxia-Inducible Factor 1, alpha SubunitSucralfateVascular Endothelial Growth Factor AAnti-Ulcer Agentsvascular endothelial growth factor A, rat

Autor:innen und Institutionen

  • Traditional Chinese Medicine Department, Dongying People's Hospital (Dongying Hospital of Shandong Provincial Hospital Group), No. 317, Dongcheng South 1 Road, Dongying, 257000, China.
  • Traditional Chinese Medicine Department, Dongying People's Hospital (Dongying Hospital of Shandong Provincial Hospital Group), No. 317, Dongcheng South 1 Road, Dongying, 257000, China. Kaiwei-Wu7@hotmail.com.

Zitieren

APA

Ren, J., Jiang, Q., & Wu, K. (2025). A novel cycloastragenol-encapsulated carboxymethyl chitosan-silk fibroin hydrogel combined with sucralfate alleviates MNNG-induced chronic atrophic gastritis by targeting HIF-1α and VEGF signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(12), 17303-17323. https://doi.org/10.1007/s00210-025-04242-4

Vancouver

Ren J, Jiang Q, Wu K. A novel cycloastragenol-encapsulated carboxymethyl chitosan-silk fibroin hydrogel combined with sucralfate alleviates MNNG-induced chronic atrophic gastritis by targeting HIF-1α and VEGF signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(12):17303-17323. doi:10.1007/s00210-025-04242-4

BibTeX
@article{Ren2025,
  author = {Ren, Jianyu and Jiang, Qianqian and Wu, Kaiwei},
  title = {A novel cycloastragenol-encapsulated carboxymethyl chitosan-silk fibroin hydrogel combined with sucralfate alleviates MNNG-induced chronic atrophic gastritis by targeting HIF-1α and VEGF signaling pathways},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {12},
  pages = {17303--17323},
  doi = {10.1007/s00210-025-04242-4}
}
Kostenlos starten →